Publication | Closed Access

Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation

TransplantationMarrow TransplantationBone Marrow FailurePediatric HematologyStem Cell TransplantationHematologyPediatricsPreemptive Alloimmune InterventionMedicineCell Transplantation